Alkermes has been granted a patent for compounds aimed at treating narcolepsy or cataplexy. The patent includes related pharmaceutical compositions and methods, focusing on a specific compound formula and its acceptable salts. GlobalData’s report on Alkermes gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Alkermes, was a key innovation area identified from patents. Alkermes's grant share as of July 2024 was 56%. Grant share is based on the ratio of number of grants to total number of patents.
The granted patent US12054495B2 outlines a novel compound represented by Formula I-A, along with its pharmaceutically acceptable salts. The claims specify various structural characteristics of the compound, including the presence of specific rings such as phenyl or pyridinyl, and variations in substituents denoted by letters Y, T, W, and V. The claims also detail the potential values for parameters such as n and m, which can be 1 or 2, indicating flexibility in the compound's structure. Additionally, the patent encompasses a pharmaceutical composition that includes the compound and a suitable carrier, emphasizing its potential utility in therapeutic applications.
The patent further describes methods for treating narcolepsy and cataplexy by administering the claimed compound or its salts to subjects in need. This highlights the compound's potential as a therapeutic agent for these sleep disorders. The extensive list of claims, including specific structural variations and applications, underscores the compound's versatility and the potential for development into a pharmaceutical product aimed at addressing these conditions.
To know more about GlobalData’s detailed insights on Alkermes, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
